Valuation: Norda ASA

Market Cap 513M 51.7M 45.27M 41.79M 39.02M 73.46M 4.89B 75.14M 503M 194M 2.41B 194M 190M 8.37B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 26.63M 23.32M 21.53M 20.1M 37.84M 2.52B 38.71M 259M 100M 1.24B 100M 97.82M 4.31B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 44.67M
+0.95%+6.02%-3.33%+2.40% 46.62B
+5.79%+16.17%+421.86%+634.63% 40.95B
+1.12%+15.18%+22.74%-12.71% 32.26B
+3.61%+6.69%+20.23%+62.38% 32.24B
+8.02%+6.35%+17.67%+34.73% 25.53B
+1.13%+15.66% - - 16.38B
+1.45%+17.35%+72.11%+127.60% 15.27B
+1.06%+5.79%+14.20%+18.67% 13.61B
-0.60%+6.32%+102.74%+96.28% 13.34B
Average +2.16%+11.58%+83.53%+120.50% 26.24B
Weighted average by Cap. +2.03%+11.59%+98.36%+145.92%

Financials

2023 2024
Net sales 86.92M 8.76M 7.67M 7.08M 6.61M 12.44M 828M 12.73M 85.18M 32.88M 408M 32.89M 32.16M 1.42B 372M 37.46M 32.8M 30.28M 28.28M 53.23M 3.54B 54.44M 364M 141M 1.75B 141M 138M 6.07B
Net income 31.17M 3.14M 2.75M 2.54M 2.37M 4.46M 297M 4.56M 30.55M 11.79M 146M 11.79M 11.54M 509M 126M 12.69M 11.11M 10.26M 9.58M 18.03M 1.2B 18.44M 123M 47.65M 592M 47.65M 46.61M 2.05B
Net Debt -311M -31.36M -27.46M -25.35M -23.67M -44.56M -2.96B -45.57M -305M -118M -1.46B -118M -115M -5.08B -249M -25.07M -21.95M -20.26M -18.92M -35.62M -2.37B -36.43M -244M -94.13M -1.17B -94.14M -92.07M -4.06B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-